Literature DB >> 17131471

Identification of squamous cell carcinoma associated proteins by proteomics and loss of beta tropomyosin expression in esophageal cancer.

Ferdous-Rastgar Jazii1, Zahra Najafi, Reza Malekzadeh, Thomas-P Conrads, Abed-Ali Ziaee, Christian Abnet, Mansour Yazdznbod, Ali-Asghar Karkhane, Ghasem-H Salekdeh.   

Abstract

AIM: To assess the proteome of normal versus tumor tissue in squamous cell carcinoma of the esophagus (SCCE) in Iranian patients and compare our results with former reports by using proteomics.
METHODS: Protein was extracted from normal and tumor tissues. Two dimensional electrophoresis was carried out and spots with differential expression were identified with mass spectrometry. RNA extraction and RT-PCR along with immunodetection were performed.
RESULTS: Fourteen proteins were found whose expression levels differed in tumor compared to normal tissues. Mass spectrometric analysis resulted in the identification of beta-tropomyosin (TMbeta), myosin light chain 2 (and its isoform), myosin regulatory light chain 2, peroxyredoxin 2, annexin I and an unknown polypeptide as the down regulated polypeptides in tumor tissue. Heat shock protein 70 (HSP70), TPM4-ALK fusion oncoprotein 2, myosin light polypeptide 6, keratin I, GH16431p and calreticulin were the up-regulated polypeptides found in tumor tissue. Several of these proteins, such as TMbeta, HSP70, annexin I, calreticulin, TPM4-ALK and isoforms of myosins, have been well recognized in tumorigenesis of esophageal or other types of cancers.
CONCLUSION: Our study not only supports the involvement of some of the formerly reported proteins in SCCE but also introduces additional proteins found to be lost in SCCE, including TMbeta.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17131471      PMCID: PMC4087770          DOI: 10.3748/wjg.v12.i44.7104

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  55 in total

1.  Aberrant ALK tyrosine kinase signaling. Different cellular lineages, common oncogenic mechanisms.

Authors:  M Ladanyi
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

2.  Human smooth muscle myosin light chain-2 gene expression is repressed in ras transformed fibroblast cells.

Authors:  C C Kumar; C Chang
Journal:  Cell Growth Differ       Date:  1992-01

Review 3.  Epidemiological aspects of oesophageal cancer.

Authors:  N Muñoz
Journal:  Endoscopy       Date:  1993-11       Impact factor: 10.093

Review 4.  The molecular basis for cellular transformation: implications for esophageal carcinogenesis.

Authors:  N Rosen
Journal:  Semin Oncol       Date:  1994-08       Impact factor: 4.929

5.  Characterization of calreticulin as a protein interacting with protein kinase C.

Authors:  E Rendón-Huerta; G Mendoza-Hernández; M Robles-Flores
Journal:  Biochem J       Date:  1999-12-01       Impact factor: 3.857

6.  Role of peroxiredoxins in regulating intracellular hydrogen peroxide and hydrogen peroxide-induced apoptosis in thyroid cells.

Authors:  H Kim; T H Lee; E S Park; J M Suh; S J Park; H K Chung; O Y Kwon; Y K Kim; H K Ro; M Shong
Journal:  J Biol Chem       Date:  2000-06-16       Impact factor: 5.157

7.  Expression of transduced tropomyosin 1 cDNA suppresses neoplastic growth of cells transformed by the ras oncogene.

Authors:  G L Prasad; R A Fuldner; H L Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

8.  Esophageal cancer trends and risk factors.

Authors:  W J Blot
Journal:  Semin Oncol       Date:  1994-08       Impact factor: 4.929

Review 9.  Silver-staining of proteins in polyacrylamide gels: a general overview.

Authors:  T Rabilloud; L Vuillard; C Gilly; J J Lawrence
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  1994-02       Impact factor: 1.770

10.  Serum levels of transforming growth factor alpha in gastrointestinal cancer patients.

Authors:  T L Moskal; S Huang; L M Ellis; H A Fritsche; S Chakrabarty
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1995-03       Impact factor: 4.254

View more
  43 in total

1.  Antibody targeting of anaplastic lymphoma kinase induces cytotoxicity of human neuroblastoma.

Authors:  E L Carpenter; E A Haglund; E M Mace; D Deng; D Martinez; A C Wood; A K Chow; D A Weiser; L T Belcastro; C Winter; S C Bresler; M Vigny; P Mazot; S Asgharzadeh; R C Seeger; H Zhao; R Guo; J G Christensen; J S Orange; B R Pawel; M A Lemmon; Y P Mossé
Journal:  Oncogene       Date:  2012-01-23       Impact factor: 9.867

Review 2.  Cell survival signaling in neuroblastoma.

Authors:  Michael L Megison; Lauren A Gillory; Elizabeth A Beierle
Journal:  Anticancer Agents Med Chem       Date:  2013-05       Impact factor: 2.505

Review 3.  ALK-immunoreactive neoplasms.

Authors:  Parham Minoo; Huan-You Wang
Journal:  Int J Clin Exp Pathol       Date:  2012-05-23

4.  Quantitative tissue proteomics of esophageal squamous cell carcinoma for novel biomarker discovery.

Authors:  Harsh Pawar; Manoj Kumar Kashyap; Nandini A Sahasrabuddhe; Santosh Renuse; H C Harsha; Praveen Kumar; Jyoti Sharma; Kumaran Kandasamy; Arivusudar Marimuthu; Bipin Nair; Sudha Rajagopalan; Jagadeesha Maharudraiah; Chennagiri Shrinivasamurthy Premalatha; Kariyanakatte Veeraiah Veerendra Kumar; M Vijayakumar; Raghothama Chaerkady; Thotterthodi Subrahmanya Keshava Prasad; Rekha V Kumar; Rekha V Kumar; Akhilesh Pandey
Journal:  Cancer Biol Ther       Date:  2011-09-15       Impact factor: 4.742

5.  The R1275Q neuroblastoma mutant and certain ATP-competitive inhibitors stabilize alternative activation loop conformations of anaplastic lymphoma kinase.

Authors:  Linda F Epstein; Hao Chen; Renee Emkey; Douglas A Whittington
Journal:  J Biol Chem       Date:  2012-08-29       Impact factor: 5.157

6.  The potential for crizotinib in non-small cell lung cancer: a perspective review.

Authors:  Yung-Jue Bang
Journal:  Ther Adv Med Oncol       Date:  2011-11       Impact factor: 8.168

Review 7.  Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy.

Authors:  Thomas R Webb; Jake Slavish; Rani E George; A Thomas Look; Liquan Xue; Qin Jiang; Xiaoli Cui; Walter B Rentrop; Stephan W Morris
Journal:  Expert Rev Anticancer Ther       Date:  2009-03       Impact factor: 4.512

8.  Epigenetic silencing of TPM2 contributes to colorectal cancer progression upon RhoA activation.

Authors:  Ji Cui; Yonghua Cai; Ying Hu; Zenghong Huang; Yanxin Luo; Andrew M Kaz; Zihuan Yang; Dianke Chen; Xinjuan Fan; William M Grady; Jianping Wang
Journal:  Tumour Biol       Date:  2016-06-23

Review 9.  Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology.

Authors:  Bengt Hallberg; Ruth H Palmer
Journal:  Nat Rev Cancer       Date:  2013-10       Impact factor: 60.716

Review 10.  Anaplastic lymphoma kinase: signalling in development and disease.

Authors:  Ruth H Palmer; Emma Vernersson; Caroline Grabbe; Bengt Hallberg
Journal:  Biochem J       Date:  2009-05-27       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.